Quince Therapeutics, Inc.
QNCX
$3.50
$0.123.60%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
12/1/2025
-
Nasdaq News: Markets
12/1/2025
-
Market News Video
11/30/2025
-
MarketBeat
11/28/2025
-
Ticker Report
11/24/2025
-
GuruFocus
11/24/2025
-
Business Wire
11/18/2025
-
MarketBeat
11/14/2025
-
MarketBeat
11/14/2025
-
MarketBeat
11/13/2025
-
GuruFocus
11/13/2025
-
SeekingAlpha.com: All News
11/13/2025
-
TipRanks Financial Blog
11/12/2025
-
GuruFocus
11/12/2025
-
GuruFocus
11/12/2025
-
The Fly
11/12/2025
-
Business Wire
11/10/2025
-
GuruFocus
11/10/2025
-
GuruFocus
11/10/2025
-
The Fly
11/10/2025
-
Business Wire
11/5/2025
-
MarketBeat
11/4/2025
-
MarketBeat
10/29/2025
-
Ticker Report
10/27/2025
-
MarketBeat
10/10/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, November 12, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 23 and 27 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
415 910 5717
Address
611 Gateway Boulevard
South San Francisco, CA 94080
South San Francisco, CA 94080
Country
Year Founded
Business Description
Sector
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company’s lead...
more